TRIM21 and rheumatoid arthritis: TRIM21 was originally identified as an autoantigen in autoimmune diseases, including rheumatoid arthritis, Systemic lupus erythematosus, and Sjogren’s syndrome (Schulte-Pelkum et al., 2009).